Is your bone health
quietly at risk?
Osteoporosis is silent until a fracture happens. This screener weighs the same clinical risk factors FRAX® uses, interprets them against Indian evidence, and turns the result into a personalised action plan. It is FRAX-informed — it is not FRAX® itself.
A screening estimate for adults aged 40–90 — not a diagnosis. Your doctor interprets the result.
1. Liang H et al. npj Aging 2025;11:78 — GBD 2021: South Asia bears the greatest burden, India the highest DALY rate. Also Safiri S et al. Health Sci Rep 2025;8:e71378. 2. Bhadada SK et al. ISBMR position statement, Arch Osteoporos 2021;16:102. 3. Lorentzon M, … Kanis JA. Climacteric 2021;25(1):4–10 — one in three women in Western societies from age 50. India-specific lifetime estimates are not established.
Quick eligibility check
This screener uses the clinical risk factors from the FRAX® framework, interpreted with Indian evidence. FRAX® itself is validated for ages 40–90, so this tool is built for that range. Please confirm which best describes you.
FRAX® (Fracture Risk Assessment Tool) was developed at the WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield. It was not developed or endorsed by the WHO itself, and calling it a “WHO tool” is a common error. It estimates a 10-year absolute probability of a major bone fracture — hip, spine, wrist or shoulder. This screener is not FRAX®: it weighs the same risk factors with its own approximation, so treat its figures as an estimated range, not an official FRAX® probability. It accounts for 8 independent clinical risk factors and produces two outputs: Major Osteoporotic Fracture (MOF) probability and Hip Fracture (HF) probability. This tool uses the India-specific calibration with ISBMR intervention thresholds.